Bacoss Bio Unveils Full-Course Digital AI+3D Printing Solution for Precision Orthopedic Care in IPO Prospectus

In an era of continuous technological advancement, patients’ growing demands for improved quality of life and medical progress are driving a shift in therapeutic approaches—from rudimentary, “one-size-fits-all” models to an era of precision, personalized medicine tailored to individual needs.

Orthopedics represents a relatively mature application scenario for personalized medicine, with its core lying in tailoring optimal treatment plans based on individual patient characteristics. However, inter-patient variability, the high-risk management of increasingly complex lesions, and poor adaptability of conventional implants leading to chronic pain and infectious complications can all adversely affect treatment outcomes and patients' quality of life.

As a cutting-edge technological paradigm in global intelligent manufacturing, 3D printing is spearheading a digital and intelligent manufacturing revolution in orthopedics and many other fields, leveraging its core advantages in personalized customization, complex structure fabrication, and biological function reconstruction.

In this context, Backus (Shanghai Backus Biomedical Technology Co., Ltd.) closely aligns with clinical needs and industry pain points by creatively proposing the “Full-Course Digital Medical AI + 3D Printing Solution.” This solution provides professional, safe, and efficient personalized diagnostic and therapeutic products and technical solutions for patients undergoing major surgical procedures, including orthopedics, across preoperative, intraoperative, and postoperative stages. Committed to serving life with cutting-edge technology, Backus aims to drive the digital and intelligent transformation of the entire healthcare industry.

“With the advancement of precision medicine, personalized diagnosis and treatment will become the core of future healthcare. Personalized orthopedic care requires customized products as support, and 3D printing technology is currently the only technical means capable of achieving this goal,” emphasized Jing Minjiang, Founder and CEO of Backus, in an interview.

As a seasoned professional in the healthcare industry, Jing Minjiang was previously responsible for the introduction and promotion of innovative medical devices at a leading state-owned enterprise (SOE) healthcare group. This experience led him to recognize that the research and development (R&D) of medical devices must be closely aligned with clinical needs; otherwise, it risks becoming an exercise in “working behind closed doors.” He recalled, “When screening projects, we adopted an investor-like mindset, focusing on clinical value, technological barriers, and market prospects.” It is precisely this long-term, in-depth reflection grounded in clinical practice that has accumulated rich product R&D experience for his current entrepreneurial ventures.

The healthcare industry is widely recognized as one of the most ideal sectors for unlocking the potential of 3D printing in global frontier technological innovation in recent years. However, based on industry developments over the past decade, the medical 3D printing sector is currently facing three major constraints:First, the delivery timeliness of personalized custom products is poor; second, the integration of implants is less than ideal; and third, existing 3D printing technology service models have limitations.

To unlock the potential of 3D printing technology, Backus has achieved breakthroughs in foundational technical areas—including hardware, software, and materials—through independent research and development and innovation. The company is committed to providing 3D printing solutions with greater clinical value and market competitiveness for the healthcare industry, thereby driving technological advancement across the sector.

First, addressing the issue of delivery timelines, Jing Minjiang provided an illustrative explanation: “Traditional 3D-printed medical implants require doctors and patients to wait at least one week. This prolonged delivery cycle is primarily due to the use of laser sintering in conventional 3D printing, which builds objects layer by layer and operates with relatively low efficiency. Even if the printer runs continuously 24 hours a day, it still takes more than 1–2 days to complete the process.”

He further emphasized, “As a digital manufacturing process, the efficient delivery of 3D printing relies on AI technology. AI is not only a core tool for improving modeling efficiency and shortening manufacturing cycles, but also a key driver in advancing 3D printing technology.”Leveraging its self-developed AI algorithms, cloud platform, and big data model of the Chinese human skeletal system, Backus aims to achieve rapid matching and customization of personalized 3D-printed implants. Combined with its proprietary printing technology, this approach can reduce delivery time by 70–80%, potentially enabling same-day delivery.

Secondly, to address the issue of rejection, Backus’s personalized custom implant solution deeply integrates 3D printing technology with bio-regenerative materials to enhance osteoconductivity, thereby effectively promoting bone ingrowth, eliminating the need for additional bone grafting, and significantly reducing surgical risks and patient complications.Meanwhile, the company has also optimized the design of the implants in terms of strength, quality, and elastic modulus, endowing them with excellent osseointegration capabilities and providing safer, more efficient solutions for orthopedic treatment.

Finally, addressing the industry’s traditional printing service model, Jiang Jingmin pointed out: “Although some suppliers engaged in industrial 3D printing can provide clinicians with the required finished 3D-printed products, they primarily operate as ‘service providers.’ Constrained by underlying original innovations in hardware, software, and materials, these ‘service providers’ often selectively overlook product safety, delivery timeliness, and cost-effectiveness. As a result, they lack autonomy and are not truly dedicated suppliers of medical 3D printing technology solutions.”Backus will focus on the deep interdisciplinary integration of new biomaterials, regenerative medicine, additive manufacturing, and artificial intelligence. Guided by clinical medical applications, the company will achieve innovative breakthroughs in foundational technologies and continuously develop and manufacture advanced digital-intelligent 3D-printed medical devices. It aims to grow into an industry-leading, technology-driven healthcare enterprise specializing in personalized customization across the entire care continuum, thereby providing patients with higher-quality, more efficient, and tailored medical solutions.

“More importantly, physicians’ time for patient diagnosis and treatment is extremely valuable. Compared with coordinating multiple vendors to obtain fragmented solutions, doctors are more inclined to choose a ‘turnkey project’-style service model, in which a single vendor assumes full responsibility for delivering personalized, customized care plans across the entire patient journey. Currently, there is a severe shortage of professional vendors capable of providing comprehensive, personalized solutions for whole-course disease management,” said Jing Minjiang.

Driven by demand, Backus is committed to providing doctors with a one-stop service covering preoperative planning, intraoperative assistance and implantation, and postoperative rehabilitation by integrating resources and optimizing processes, thereby achieving the goal of reducing the burden on doctors and enhancing benefits for patients.

During the preoperative phase, Backus combines artificial intelligence, image segmentation technology, and 3D printing technology to transform patients' two-dimensional imaging data into tangible three-dimensional physical models. These physical models can clearly and intuitively present the morphology and structure of diseased tissues, thereby assisting doctors in formulating more precise surgical plans. Furthermore, through its proprietary special printing process, same-day delivery is expected to be achieved.

Compared with computer-based 3D reconstruction, physical models can also avoid issues such as data loss and visual interference, thereby ensuring the integrity and accuracy of diagnostic and treatment information. This technology is particularly effective in mitigating diagnostic errors caused by insufficient experience among young physicians and those practicing at primary care levels.

Furthermore, 3D-printed models provide visual support for doctor-patient communication, enabling physicians to intuitively demonstrate surgical plans to patients. Jing Minjiang emphasized, “3D-printed preoperative planning models are not merely surgical planning tools; they also serve as a bridge that fosters communication and trust between doctors and patients.”

During the intraoperative phase, 3D printing also plays a crucial role. Physicians can accurately locate lesions using 3D-printed intraoperative positioning guides, thereby reducing surgical time and blood loss while improving surgical success rates. Jing Minjiang stated, “Traditional standardized positioning blocks struggle to accommodate individual patient variations, whereas 3D-printed positioning guides enable precise fit, significantly enhancing surgical safety and efficiency. Furthermore, by leveraging artificial intelligence and cloud platform technologies, combined with proprietary specialized printing processes, this model can reduce surgical costs by 60% and shorten product delivery times by 70–80%, enabling rapid delivery of positioning guides that meet clinical needs within 3–5 hours.”

Furthermore, Backus will dedicate greater resources to the research and development of integrating bio-regenerative materials with personalized implants. The implants feature novel bioactive coatings on their surfaces to promote bone growth, achieve superior osseointegration, and reduce the risk of complications associated with traditional restorative materials. Additionally, proprietary advanced printing technologies are employed to enhance delivery efficiency.

In the post-operative phase, Backus has accumulated substantial innovative expertise across hardware, software, and materials. This is exemplified by its initial Phase I product—the 3D Printing System for Digital and Intelligent Orthopedic Rehabilitation Braces—which achieves a printing efficiency more than 80% higher than that of traditional 3D printing technologies. On the software front, the company has integrated modeling and slicing functionalities into a single intelligent modeling and slicing software package. Requiring minimal manual intervention, the software allows users to complete the entire operation by entering just two or three data points and clicking the mouse a few times, thereby achieving fully automated modeling and slicing. The entire workflow, from scanning the patient’s injured area to completing the print, takes only 20–30 minutes, compared to the 3–5 hours required by traditional 3D printing processes. This significant time reduction greatly enhances clinical capabilities for immediate care.

Furthermore, compared with traditional external fixation devices such as plaster casts and polymer splints, the company’s new-generation 3D-printed orthopedic rehabilitation brace is the world’s first thermoplastic high-speed 3D-printed rehabilitation brace. Made from biocompatible, skin-friendly materials, it offers advantages including safety, breathability, re-moldability, and biodegradability. It can comprehensively address both closed and open bone injuries, resolving the issue that traditional braces cannot be reused after swelling subsides. Moreover, it weighs only 1/20th of a traditional plaster cast of equivalent specifications. More importantly, the production cost is reduced by 80% compared to conventional 3D-printed braces, significantly alleviating the financial burden on patients.

As personalized medicine and precision medicine advance in depth, 3D printing technology is accelerating the restructuring of healthcare service systems, driving the industry toward greater efficiency and customization. According to research data from SN SInsider, the global market size for 3D-printed medical devices reached $2.69 billion in 2023 and is projected to climb to $11.46 billion by 2032, with a compound annual growth rate (CAGR) of 17.5% from 2024 to 2032.

To leverage the power of interdisciplinary research and accelerate the development and application of new technologies, Backus will advance collaborations with the top 2,000 key hospitals at or above the county level across China, as well as renowned private chain orthopedic hospitals. By jointly establishing regional digital medical-biological 3D printing centers, Backus will provide personalized, customized product and technical service solutions for entire surgical departments within these hospitals. This initiative aims to facilitate the decentralization of medical resources and support the advancement of tiered diagnosis and treatment.

“Backus will obtain the medical device registration certificate for its 3D-printed rehabilitation braces in the second half of 2025, and officially launch them in the first half of 2026, enabling the company to rapidly achieve self-sustaining revenue generation.”Jing Minjiang stated. In addition, Backus is also expanding its business boundaries based on big data and cloud platform technologies. “The company is developing an online interactive orthopedic cloud platform, aiming to achieve deep integration of doctor-patient resources through this platform. On the cloud platform, doctors can access professional academic educational resources, while patients can choose trusted physicians for paid consultations,” Jing Minjiang introduced.

From surgical assistance to medical device manufacturing, and from drug development to bioprinting of tissues, the current 3D printing industry in healthcare is experiencing rapid growth, with its market scale expanding at an accelerated pace.Looking ahead, Jing Minjiang is full of confidence: “With continuous technological iterations and the gradual maturation of the market, the application prospects of 3D printing technology in the medical field will become even broader. Personalized custom products will gradually achieve mass production and are expected to replace traditional conventional implants. This means that in the future, every patient will be able to use personalized custom products tailored to their own physique, thereby receiving comprehensive, efficient, and precise personalized diagnosis and treatment.”